U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954181) titled 'Quantification of Diclofenac 2.32% (Voltaren) in Rinse Water After Different Application Methods' on April 24.
Brief Summary: The purpose of this study is to quantify the amount of diclofenac in rinse water after application of the test product (Voltaren(R) Schmerzgel forte; 2.32 percent [%]) containing 2.32% Diclofenac-N-Ethylethanamin either by hand or using an applicator and subsequent washing and/or wiping.
Study Start Date: March 26
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Voltaren(R) Schmerzgel forte; 2.32% (Test Product)
Voltaren(R) Schmerzgel forte; 2.32% containing 2.32% Diclofenac...